Impact of Protocol Deviations in Acute Ischemic Stroke Treated With Intravenous rt-PA Within 4.5 Hours After Symptom Onset

scientific article published on July 2012

Impact of Protocol Deviations in Acute Ischemic Stroke Treated With Intravenous rt-PA Within 4.5 Hours After Symptom Onset is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1941874412441802
P932PMC publication ID3726086
P698PubMed publication ID23983868
P5875ResearchGate publication ID256190627

P50authorYazan J. AlderaziQ47820716
P2093author name stringJ P Yang
J Chang
Lucas Restrepo
A Awad
K Chapple
M Teleb
P2860cites workClassification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke TreatmentQ22306370
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic strokeQ29619330
Retrospective assessment of initial stroke severity with the NIH Stroke ScaleQ33885232
Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.Q35187798
Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trialQ37300424
Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis.Q37301824
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.Q37436384
Is thrombolysis safe in the elderly?: analysis of a national databaseQ44771011
Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradoxQ45082453
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsQ47963971
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trialQ48426796
Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle timeQ48943674
Acute stroke with atrial fibrillation. The Copenhagen Stroke StudyQ51004375
Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational studyQ81963102
P433issue3
P304page(s)82-86
P577publication date2012-07-01
P1433published inThe NeurohospitalistQ26853983
P1476titleImpact of Protocol Deviations in Acute Ischemic Stroke Treated With Intravenous rt-PA Within 4.5 Hours After Symptom Onset
P478volume2

Reverse relations

Q92999035Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic strokecites workP2860

Search more.